Are You in Control of Your Data

New ProtoCOL 2 Speeds Up Quality Testing of Swine Flu Vaccines

ProtoCOL 2 automated zone reader
The innovative ProtoCOL 2 automatic zone measuring system from Synbiosis can increase the speed of quality testing of H1N1 swine flu virus vaccine potency, ensuring vaccines can be rapidly delivered to healthcare professionals.

The ground breaking ProtoCOL 2 takes zone measurement technology to a new level with its unique functionality and performance, and can generate results from a 16-zone SRD (Single Radial Immunodiffusion) plate of swine flu vaccines in minutes. This means using a ProtoCOL 2, manufacturers can produce highly accurate and reproducible indications of vaccine potency up to ten times faster than time consuming and error-prone manual techniques.
The ergonomically designed ProtoCOL 2 has sliding doors to eliminate ambient light and the system's unique red, blue and green LED lighting (patent pending) provides exceptional uniform illumination of SRD plates offering good contrast and reflection-free detection. The unit contains a high-resolution CCD camera that captures precise zone images in seconds and its new advanced Zone software can rapidly calculate a precise average diameter to provide an accurate indication of vaccine potency. These innovative features save hours of highly repetitive work to make ProtoCOL 2 ideal for increasing productivity in any GMP vaccine production facility.

The reproducible results can be automatically transferred with a one button click into the statistical analysis module and an image library is also created alongside. These files ensure producing professional reports for each batch of swine flu vaccine, accepted by major regulatory authorities, is a straightforward task.

Martin Smith of Synbiosis commented: 'Although, swine flu is not generally causing serious illness in patients, health officials are preparing for one of the biggest winter vaccination campaigns in almost 50 years, and the UK government has ordered enough vaccine to cover the entire population.'

Martin Smith added: 'Due to this short-term surge in demand for swine flu vaccine, manufacturers that can have theirs available first are likely to benefit the most. This is where using our ProtoCOL 2 system will help because automating analysis of SRD plates means vaccine potency can be determined in minutes not hours, thus reducing production timelines and allowing more rapid release of vaccines to healthcare professionals.'


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source: Synbiosis View latest company information

Posted: October 20, 2009
Request Information
[will open your email client]

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed